Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer

A technology of vinylpyrrolidone and polyethylene glycol, which is applied in the field of film preparation and its preparation, can solve problems such as layer separation and uneven active ingredients, and achieve the effect of reducing the amount of bubbles

Active Publication Date: 2015-12-30
CTC BIO INC
View PDF8 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] When tadalafil is manufactured in an insufficiently dissolved state or in a dispersed or suspended state, it may cause layer separation of the film for preparing the solution and unevenness of the active ingredient due to strong water repellency

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer
  • Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer
  • Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0047] Preparation of film formulation containing tadalafil free base >

[0048] A film formulation containing tadalafil free base was prepared as follows. Plasticizers, additives, sweeteners, surfactants, and dispersion stabilizers are added to purified water, stirred until dissolved or dispersed in the purified water, and tadalafil free base is added thereto. Subsequently, homogenization was performed using a homogenizer (Ultraturrax T-25, IKA). Add polymer to it and homogenize with the same homogenizer. Then, the gas was removed from the film preparation solution under vacuum at 45° C., and after cooling to room temperature, it was coated with a polyethylene (PE) film of the most suitable thickness. Then, drying was performed at 80°C to prepare a film formulation containing tadalafil free base.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a film preparation for oral administration, containing tadalafil free base, and a preparation method therefor. The invention provides a film. It is possible to: maximize the dispersion stability of tadalafil free base in the film by using a small amount of a dispersion stabilizer without inducing a specific odor or taste which can occur when using other dispersion stabilizers known in the relevant art; provide a film having an extremely low rate of tadalafil free base particle reaggregation; and remarkably reduce the amount of bubbles during a preparation process.

Description

Technical field [0001] The present disclosure relates to a film preparation containing tadalafil free base (tadalafilfreebase) as an active ingredient and a preparation method thereof. More specifically, the present disclosure relates to a film containing tadalafil free base with content uniformity and dispersion uniformity, and a method for preparing tadalafil free base with content uniformity and dispersion uniformity Of the membrane method. [0002] This application claims the priority of Korean Patent Application No. 10-2013-0040084 filed in Korea on April 11, 2013, and the disclosure of the patent application is incorporated herein by reference in its entirety. Background technique [0003] The active ingredient of Tadalafil (Tadalafil) has been used to treat male erectile dysfunction. The prescription information for this product describes this product as an almond-shaped oral drug coated with a film containing tadalafil, and records the following inactive ingredients: cro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/70A61K47/38A61K47/30
CPCA61K47/38A61K9/7007A61K47/10A61K9/006A61K47/36A61K9/0056A61K31/4985A61K47/32A61P15/10A61K47/34
Inventor 全泓烈权度又李凤相朴秀晙车奉根金准基韩知姈吉明哲
Owner CTC BIO INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products